Skip to content

Pediatric and Ambulatory Research in Infectious Diseases

Real Time Surveillance of Pediatric Infectious Diseases in French Ambulatory Care: PARI Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04471493
Acronym
PARI
Enrollment
400000
Registered
2020-07-15
Start date
2017-06-26
Completion date
2030-08-02
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis, Gastroenteritis, Influenza, Otitis, Pharyngitis, Pneumonia, Varicella

Keywords

Vaccination, Antibiotic treatment, Point of care test, automated data extraction, network

Brief summary

Many ambulatory networks are mainly based on diagnoses made by first-line physicians not specifically trained to join the network. Here we aim to set up a surveillance network on pediatric infectious diseases with an investment in teaching with specific trainings of participating pediatricians, increasing in use of point of care tests, and automated data extraction from the computers of the pediatricians.

Detailed description

107 pediatricians among the 1400 members of the French ambulatory pediatric association, AFPA (Association Française de Pédiatrie Ambulatoire) were involved in this survey.To belong to the PARI network, pediatricians have to use the same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France) for electronic medical record of children. The pediatricians were trained to the use of point of care tests and to the infectious diagnoses (otitis, pharyngitis, varicella, bronchiolitis, influenza, pneumonia, etc..). The study population consisted of all children under 16 years of age from the patient population for which an infectious disease was diagnosed.

Interventions

None listed

Sponsors

AFPA (Association Française de Pédiatrie Ambulatoire)
CollaboratorUNKNOWN
GlaxoSmithKline
CollaboratorINDUSTRY
Sanofi
CollaboratorINDUSTRY
Pfizer
CollaboratorINDUSTRY
Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
Association Clinique Thérapeutique Infantile du val de Marne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 16 Years

Inclusion criteria

* Children under 16 years of age with at least one infectious disease among: * pharyngitis * otitis * pneumonia * influenza * bronchiolitisz * varicella * gastroenteritis * enterovirus disease * bordetella pertussis disease * using the same same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France)

Exclusion criteria

* parental refusal

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the number of infectious diseases5 yearsproportion of children under 16 years, with infectious disease

Secondary

MeasureTime frameDescription
Evaluation of the use of point of care tests5 yearsProportion of use of point of care tests and positivity rate according to the infectious diseases
Evaluation of the antibiotic treatments5 yearsProportion of each antibiotic treatments according to the infectious diseases

Countries

France

Contacts

Primary ContactCorinne LEVY, MD
corinne.levy@activ-france.fr0033148850404
Backup ContactStéphane Béchet, MSc
stephane.bechet@activ-france.fr0033148850404

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026